| Authors: |
Primi MC; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02215, United States., Tavares MT; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02215, United States., Hatcher JM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02215, United States., Kang H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States., Kresina TAC; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States., Chakraborty S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02215, United States., Leroy E; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02215, United States., Schmoker AM; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02215, United States., Jeon H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02215, United States., Weisberg EL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States; Department of Medicine, Harvard Medical School, Boston, MA, 02215, United States., Akatsu T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States., Griffin JD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States; Department of Medicine, Harvard Medical School, Boston, MA, 02215, United States., Scott DA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02215, United States., Eck MJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, United States; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02215, United States. Electronic address: michael_eck@dfci.harvard.edu. |
